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Abstract
Background: Brucellosis is an emerging yet neglected zoonosis that has been reported in Kenya. Epidemiological
data on brucellosis in ruminants is readily accessible; however, reports on brucellosis in pigs remain limited. This
study sought to detect Brucella infection in pig serum by both serological and molecular techniques. Serum from
700 pigs randomly collected at a centralized abattoir in Nairobi region, Kenya were screened in parallel, using both
Rose Bengal Test (RBT) and competitive Enzyme-Linked Immuno-sorbent Assay (cELISA) for antibodies against
Brucella spp. All sera positive by RBT and 16 randomly selected negative samples were further tested using
conventional PCR targeting bcsp31 gene and real-time PCR (RT-PCR) assays targeting IS711 and bcsp31 genes.
Results: A prevalence of 0.57% (n = 4/700) was estimated using RBT; none of these samples was positive on cELISA.
All RBT positive sera were also positive by both PCRs, while two sero-negative samples also tested positive on RT-
PCR (n = 6/20). Brucella abortus was detected in four out of the six PCR positive samples through a real-time
multiplex PCR.
Conclusion: The detection of antibodies against Brucella spp. and DNA in serum from slaughterhouse pigs confirm
the presence of Brucella in pigs. Therefore, investigation of the epidemiology and role of pigs in the transmission of
brucellosis in Kenya is needed. Further targeted studies would be useful to systematically quantify and identify the
spp. of Brucella in pigs.
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Background
Brucellosis is a neglected zoonotic disease with a world-
wide distribution [1]. It affects a broad range of wild and
domesticated animals and is responsible for economic
losses due to reduced milk yields, infertility and abor-
tions in infected animals [2]. While there are numerous
species of the bacterial genus Brucella, those most com-
monly associated with human infections are B. meliten-
sis, B. abortus and B. suis, largely affecting small
ruminants, cattle, and pigs, respectively [3]. Over 500,
000 new human cases of brucellosis are reported annu-
ally globally [4]. Humans can get infected with brucel-
losis via direct or indirect contact with infected animals
and through the consumption of undercooked or raw
animal products. Therefore, control of brucellosis in ani-
mals can reduce new cases of human brucellosis. In
Kenya, brucellosis is among the top priority zoonotic
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diseases for integrated ‘One Health’ control, but the
focus is limited to ruminants, for which data on their
importance as a significant source of human infection
with Brucella is available [5, 6].
The species, B. suis, is considered as one of the three
most common zoonotic pathogenic species to humans
[1]. Nonetheless, data on the epidemiology of pig brucel-
losis in Kenya remains very sparse, with no recently gen-
erated reports. The only documented information on pig
brucellosis was produced more than four decades ago,
through a serological survey that reported the presence
of Brucella antibodies in pigs with a prevalence of 0.2%
[7]. Despite this, pork production and consumption are
among the most rapidly growing livestock sectors in
Kenya, with a predicted overall production growth rate
of 203% for the period between 2000 and 2030 [8].
The Rose Bengal test (RBT) is the World Organisation
for Animal Health (OIE) recommended screening test
for brucellosis in animals [9]. However, several studies
have reported false positivity with this test due to cross
interaction with Y. enterocolitica O:9, which is quite
prevalent in pig populations [10, 11]. The confirmation
of the RBT by Enzyme-Linked Immuno-Sorbent Assays
(ELISAs) also suffers from reportedly low sensitivity in
pig sera [10, 11]. These limitations generally suggest that
serological testing of pig serum with the recommended
tests may not be ideal and that results should, therefore,
be interpreted with caution.
The development of molecular-based assays for the
rapid and specific detection of Brucella DNA has signifi-
cantly advanced our understanding of host-pathogen in-
teractions. Previous serology-based surveys traditionally
assumed that Brucella spp. have host preference [10,
11]. Recent studies have shown that there is indeed a
complex and diverse distribution of the pathogen among
different hosts, further complicated by farming systems
and close interactions between wildlife and livestock
[12]. Quantitative, real-time PCR assays, such as those
developed by Matero et al. [13] and Probert et al. [14],
have also significantly increased the ease of detection of
Brucella DNA, moreover, with the extraction of genomic
material directly from clinical specimens [15]. These test
options and findings have shed light on the complicated
epidemiology and transmission of brucellosis between
different hosts which, unfortunately, have not been ap-
plied to the pig population in sub-Saharan Africa. There
is a scarcity of reported studies in Africa in detecting
brucellosis in pigs by molecular techniques, besides the
insufficient information on B. suis infection in the re-
gion. Therefore, the understanding of the role of pigs in
the transmission dynamics of brucellosis remains lim-
ited. Previous studies have looked into pork value chains
and their potential role in the transmission of other pri-
ority zoonoses [16, 17]. This study was therefore done to
detect and identify Brucella spp. in pigs entering the
Nairobi pork market. In so doing, we identified exciting
variations to our current understanding of host species dis-
tributions and diagnostic challenges for brucellosis in pigs.
Results
A total of 700 pigs were sampled at a central abattoir
[16]. Pigs from all over Kenya were eligible for inclusion
in the study; most sampled pigs originated from the cen-
tral region (n = 427; 61%) and Nairobi (n = 159; 22.7%).
Majority of the sampled pigs were female (n = 469;
67.0%). The pig sera were tested for antibodies against
Brucella spp. using RBT and cELISA. Four out of the
seven hundred sera tested by RBT were positive, while
none were positive by cELISA (Table 1). The four RBT
positive samples, together with 16 randomly selected
RBT negative samples were also tested by PCR for detec-
tion of Brucella spp. DNA.
Out of the 20 samples selected for molecular analysis, 4
samples amplified the target region of interest on molecu-
lar testing using conventional PCR, giving an anticipated
band of 223 base pairs. Data shown in Additional file 1:
(Detection of Brucella DNA using conventional PCR
method: Electronic supplementary material).
Six out of the 20 samples tested by real-time PCR
amplified with both the bcsp31 and the IS711 genus-
specific primers used to detect the presence of Brucella
DNA. Amplification with the B. abortus primers was
also achieved with 4 of these 6 samples. None of the
samples amplified with the B. melitensis specific primers
(Table 2).
Discussion
We detected the presence of Brucella DNA in pig sera
that also screened positive using the RBT. According to
our knowledge, this is the first report of molecular de-
tection of Brucella spp. in pig serum in East Africa. Bru-
cellosis is a widespread zoonotic disease and serological
evidence of pig brucellosis has previously been described
in Africa [15, 18–22]. However, information on B. spp.
circulating in the pig population remains limited. South
America and Southeast Asia are considered to have a
higher prevalence of porcine brucellosis, as compared to
the other regions, including Africa [1]. The sero-
positivity of 0.57% detected in this study is consistent
with findings from different serological studies con-
ducted in other African countries such as Nigeria [19,
20, 22], Zambia [22] and Uganda [20], which reported
prevalence of between 0 and 0.6%. However, our results
differ with one study that reported a high sero-prevalnce
of 30.6% in Benue State of Nigeria [21]. The high preva-
lence reported in Benue State, however, could be due to
the clustering of positive animals in the targeted region,
as other studies in Nigeria also reported lower
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prevalence rates [18, 23]. Despite the low prevalence of
0.57% detected from the pig population in this study, the
risk of transmission in the pig population may grow with
the rapidly growing pig production in Kenya, especially
if control interventions are not put into place.
In this study, we found that four out of the six positive
samples detected were of B. abortus, as they amplified
with B. abortus primers [14]. The other two samples that
did not amplify with the species identification primers
could belong to a different species, given that the assay
is designed to distinguish between B. abortus and B.
melitensis [14]. The detection of zoonotic Brucella spp.
in pig sera, and more so B. abortus, is of importance
given that pigs are traditionally associated with B. suis,
while cattle are considered to be the preferred host for
B. abortus [1]. This finding therefore highlights the pos-
sibility for novel transmission dynamics within pigs and
the need for further investigations to inform appropriate
control strategies for brucellosis in Kenya and similar
settings. The number of studies that have used serum
samples for extraction of genomic DNA, and subsequent
detection of Brucella DNA, has increased in the recent
past [13, 15, 20]. This could be due to the fact that
serum samples can be used for routine testing of brucel-
losis in both animals and humans since, unlike other
samples such as abortion materials, swabs, hygromas
and milk, they are not affected by the age, sex or physio-
logical stage (such as pregnancy). Even though Brucella
spp. are known to have host preference, cross-infection
has previously been reported to be common in areas
where mixed husbandry systems are practised [11, 24,
25].
Similarly, the presence of B. melitensis in pigs’ serum
was recently reported in Egypt [15]. In that study, the
prevalence was comparable to a previous report from
Latin America where B. melitensis was detected in pigs
[26]. In the current study, the positive pigs were sourced
from peri-urban and slum areas, where small-scale
farmers keep mixed herds that facilitates close contact
between the different animal species. Free-range systems
practised in the informal settlements, and feeding of pigs
on waste from the market [27] could also contribute to
the cross-transmission of B. abortus from cattle to pigs.
The presence of B. abortus in pigs may not only present
a zoonotic risk to non-suspecting farmers, slaughter-
house workers and pork consumers but also raises the
need for further investigation on the epidemiology and
pathogenicity of B. abortus in pigs, as well as their con-
tribution to human infection.
The Rose Bengal Test (RBT), Buffered Plate Agglutin-
ation Test (BPAT) and ELISA are recommended sero-
logical tests for screening brucellosis in pigs [1].
However, the results from these tests should be con-
firmed by reference serology tests or confirmatory bac-
teriology and molecular techniques [10, 11, 28, 29].
Variability between the performance of different
Table 1 Serological and molecular detection of Brucella antibodies and DNA in pig sera in Kenya
Test performed Number tested Number/proportion of positive
RBT 700 4 (0.57%)
cELISA 700 0 (0.00%)
Conventional PCR, genus specific target (bcsp31) 20 4 (20.00%)
qPCR, IS711 and bcsp31targets 20 6 (30.00%)
qPCR, B. abortus specific target (alkB) 6 4 (66.67%)
qPCR, B. melitensis specific target (BMEI1162) 6 0 (0.00%)
Table 2 Results for RBT and Real-Time PCR positive samples (n = 6)
Samples Source Sex RBT results Conventional PCR Genus specific (IS711&
bcsp31)
B.
abortus
specific
B.
melitensis
specific
Serum Central region
Peri-urban
Female -ve not done +ve +ve -ve
Serum Rift valley region
Peri-urban
Female +ve +ve +ve -ve -ve
Serum Central region
Peri-urban
Female +ve +ve +ve -ve -ve
Serum Western region
Peri-urban
Male -ve not done +ve +ve -ve
Serum Central region
peri-urban
Male +ve +ve +ve +ve -ve
Serum Nairobi region
Slum
Male +ve +ve +ve +ve -ve
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serological tests, or in the sensitivities and specificities
for the same tests using pig serum in different studies,
have been recorded [28, 30, 31]. This study also ob-
served a poor agreement between the RBT and cELISA,
which is similar to the findings in other studies [30, 31].
Further investigation should be carried out to evaluate
the performance of these two assays on pig samples.
There was a much better agreement between the con-
ventional and qPCR. All four positive samples detected
by conventional PCR (B4/B5 primers) were further con-
firmed by a multi-level genus- and species-specific RT-
PCR. Brucella abortus was identified in four of the six
positive samples. The agreement between molecular and
serological tests raises an important consideration for
these tests to be used for routine testing (surveillance) of
brucellosis in livestock and wildlife.
This study had several limitations; first, not all 700
sera screened by the RBT and cELISA were tested by
PCR. This could downplay the positivity proportion de-
tected in the molecular assays used. Secondly, the time
lapse between the serology (September 2018) and mo-
lecular testing (November 2019) implies that study
personnel were not entirely blinded to the results of the
initial screening when conducting PCR. Finally, the lim-
ited scope of the species identification technique used
(B. abortus and B. melitensis) could imply that other
Brucella spp., including a possibly novel species in this
pig population, could have been missed in this study. Fu-
ture studies should consider the suitability of different
assays for the detection of pig brucellosis since it is an
emerging area of research. All the assays used in this
study are not explicitly designed for pig host testing, ra-
ther the assays are generally applied to the detection of
Brucella antibodies and DNA. This could affect the sen-
sitivity or specificity of detecting brucellosis in pigs, es-
pecially when a single test is used. Therefore, future
studies should evaluate a range of tests for utility in test-
ing for brucellosis within this crucial population.
Conclusion
Brucella antibodies and DNA were detected in pig sera
from slaughterhouses in Nairobi, Kenya. Further tar-
geted studies to systematically quantify and speciate the
strain of Brucella in pigs should be conducted.
Methods
Study site
The study was conducted at the largest pig abattoir that
supplies unprocessed pork to consumers in the city of
Nairobi. The abattoir is located at the outskirts of
Nairobi and obtains pigs from all production regions in
Kenya.
Sampling and data collection
A total of 700 blood samples were collected from pigs in
a prevalence study on pig cysticercosis, as previously de-
scribed [16]. All pigs presented for slaughter from the
months of October to December 2014 were eligible for
sampling [16]. Based on the data available from Kenya at
the time of the parent study design, an assumed preva-
lence of 32.8% was used, with a 95% confidence level
and a precision of 5%, to obtain an adequate sample size
for the estimation of the population prevalence of cysti-
cercosis [16]. Pigs were systematically selected; the first
pig presented for slaughter was sampled, followed by
every fifth, to get an average of 15 pigs each day for 47
days. Approximately 10 ml of blood were collected from
each pig into a plain vacutainer tube (BD Vacutainer). A
brief questionnaire was administered to the pig owner
(farmers or traders), to capture information including
the origin/location, sex, and age of the sampled pigs.
The blood samples were temporarily stored at 2–8 °C
before transportation to the International Livestock Re-
search Institute (ILRI) laboratories in Nairobi, Kenya.
The samples were then centrifuged at 2500 rpm for 20
min and serum aliquoted into 2ml sample tubes for
storage at − 80 °C until testing.
Serological testing
Rose Bengal test (RBT)
The Rose Bengal Test (RBT) was carried out using anti-
gens provided by Instituto de Salud Tropical Universi-
dad de Navarra @ Edificio CIMA AvdaPioXII, 55 E-
31008 Pamplona, Spain. The testing was carried out ac-
cording to the OIE protocol [9]. Briefly, all 700 serum
samples and the antigen were defrosted at room
temperature. About 25 μl of the sample was dispensed
onto the glossy side of a white tile. An equal volume of
the antigen was then dispensed beside each drop of
serum. Each plate was prepared with negative and posi-
tive controls also provided with the kit. The antigen and
serum were immediately mixed using a wooden splint,
and the plate rocked gently for 4 minutes. Following
this, the results were read immediately in a well-lit place
and interpreted as either positive or negative. Samples
were considered positive for RBT when there was any
degree of visible agglutination at 4 minutes [9].
Competitive enzyme-linked immunosorbent assay
(cELISA) testing
The ELISA testing was done on all the 700 samples
using competitive ELISA kit, COMPELISA 400 (cELISA
APHA Scientific, Weybridge-UK) for detection of anti-
Brucella antibodies. The cELISA testing was conducted
as per the manufacturer’s instructions as follows; all re-
agents and serum samples were first brought to room
temperature. Serum samples (20 μl) were added to each
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well of the ELISA plates that are pre-coated with puri-
fied standard sLPS antigen prepared from B. melitensis
isolates and mixed with 100 μl of the freshly prepared
conjugate. Positive and negative controls were included
in each test run. After incubation at room temperature
for 30 min and constant mixing on a rotary shaker, the
plates were washed five times with the wash solution.
Then 100 μl of chromogen substrate was added to each
of the wells, incubated at room temperature for 15 min
and the reaction stopped by adding 100 μl of stopping
solution to each well. The Optical Density (OD) was de-
termined using an ELISA reader (BioTek Synergy HT,
BioTek Winooski, VT 05404 United States) at a wave-
length of 450 nm. A plate was considered valid if the
mean OD of the 6 negative controls at 450 nm was
greater than 0.700, and the mean OD of the 6 positive
controls was less than 0.100 [32]. The difference be-
tween the OD of the positive and negative controls had
to be equal to or greater than 0.300. A cut-off was deter-
mined using the conjugate control, i.e. 60% of the mean
OD of the four conjugate control wells [28, 30]. Any OD
equal to or below the determined cut-off value was con-
sidered as being positive, while values above cut-off were
considered negative [32].
Molecular detection
Sample selection
The RBT positive samples plus additional randomly se-
lected RBT negative samples (4 RBT negative sera se-
lected for each of the RBT positive samples), were
processed for molecular testing. We estimated the sam-
ple size based on the sample required to detect a mini-
mum number of 4 positive events at a 95% confidence,
given a positivity of 33%. This gave us a minimum sam-
ple estimate of 20. All the molecular testing was con-
ducted at ILRI between November and December 2019.
Extraction and purification of DNA
Extraction of genomic DNA was done from 200 μl of the
serum using QIAamp™ DNA Mini Kit, (QIAGEN,
Germany), according to the manufacturer’s guidelines.
Briefly, 20 μl of proteinase K and 200 μl of genomic lysis
buffer were added to the source sample. The mixture
was subjected to digestion, deactivation, washing and
elution steps as per the manufacturer’s guidelines. The
DNA quality and quantity were determined using a
NanoDrop™ 2000c Spectrophotometer (ThermoFisher
Scientific, USA). Stock DNA samples were stored at −
20 °C until the performance of PCR.
Conventional PCR detection of Brucella DNA
Molecular identification of the genus Brucella was done
using two sets of primers: B4 forward (5′-TGG CTC
GGT TGC CAA TAT CAA-3′) and B5 reverse (5′-CGC
GCT TGC CTT TCA GGT CTG-3), as previously re-
ported [29].
Real-time PCR detection of Brucella DNA
Real-time PCR was performed on all the extracted DNA
samples using an ABI 7500 thermocycler machine (Ap-
plied Biosystems, Life Technologies, Singapore), begin-
ning with a Brucella genus-level screening using two
primers targeting IS711 gene and bcsp31 gene, respect-
ively [13, 14]. The species identification using B. abortus
and B. melitensis-specific primers and probes, was subse-
quently performed on DNA samples that showed any
amplification with both targets bcsp31 and IS711
primers. This second round multiplex qPCR was per-
formed using previously developed oligonucleotide
primers and probes [14] as indicated in Table 3 below.
Briefly, template DNA (4 μl) were mixed with 0.5 μM
each of the primers targeting the alkB for Brucella abor-
tus, BMEI1162 for B. melitensis and 0.25 μM of fluores-
cent probe (primer and probe sequences are given in
Table 3). About 10 μl of the Luna® Universal Probe
qPCR mastermix (404 with UDG; New England BioLabs,
MA, USA) was added to each oligonucleotide and DNA
sample mixture. The reaction mixture (20 μl) was then
run on an Applied Biosystems 7500 Real-Time PCR Sys-
tem (Applied Biosystems, USA). All the samples and
Table 3 Primers and probes used for real-time PCR
Target Gene targeted Sequences of primers and probes (5′ -3′) Fluorophore/ quencher Reference
Genus Brucella IS711 Forward GGCCTACCGCTGCGAAT
Reverse TTGCGGACAGTCACCATAATG
Probe AAGCCAACACCCGGC
FAM/−MGBNFQ Matero, 2011 [13]
Genus Brucella Bcsp31 Forward GCTCGGTTGCCAATATCAATGC
Reverse GGGTAAAGCGTCGCCAGAAG
Probe AAATCTTCCACCTTGCCCTTGCCATCA
6-FAM/BHQ1 Probert, 2004 [14]
B. abortus IS711 downstream of alkB Forward GCGGCTTTTCTATCACGGTATTC
Reverse CATGCGCTATGATCTGGTTACG
Probe CGCTCATGCTCGCCAGACTTCAATG
JOE/BHQ1
B. melitensis IS711 downstream of BMEI1162 Forward AACAAGCGGCACCCCTAAAA
Reverse CATGCGCTATGATCTGGTTACG
Probe CAGGAGTGTTTCGGCTCAGAATAATCCACA
Texas Red/BHQ2
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control mixtures were tested in duplicate using the fol-
lowing parameters: 2 min of decontamination at 95 °C,
followed by 10min of denaturation and activation of
polymerase at 95 °C, then 45 cycles of 95 °C for 15 s and
57 °C for 1 min. A sample was considered positive if it
amplified in one or both wells with a cycle threshold
(Ct) values < 39. Positive controls 16M B. melitensis and
544 B. abortus (sourced from Friedrich-Loeffler-
Institute, the Brucella reference lab in Germany) and
non-template controls were included in all the real-time
PCR runs.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12917-020-02346-y.
Additional file 1. Detection of Brucella DNA using conventional PCR
method.
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